Viewing Study NCT04554459


Ignite Creation Date: 2025-12-24 @ 3:04 PM
Ignite Modification Date: 2025-12-28 @ 2:28 AM
Study NCT ID: NCT04554459
Status: TERMINATED
Last Update Posted: 2024-08-14
First Post: 2020-09-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph+ ALL
Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module